That careful acknowledgment of contributors also points to a broader principle: when outcomes matter, quality depends on traceability, standards, and accountability rather than anonymity. In health care, the same logic applies to high-quality antibiotics, where the difference between a verified product and a dubious substitute can determine whether an infection resolves or becomes harder to treat. “Quality” here is not a slogan but a chain of controls validated manufacturing, correct dosing, and reliable storage conditions that must hold from production to dispensing. When those links break, patients pay twice: first with persistent symptoms, and later with the societal cost of antimicrobial resistance driven by subtherapeutic or inappropriate use. That’s why responsible access matters as much as chemistry, and why antibiotics should be framed as targeted tools used under clinical guidance, not as generic fixes for any discomfort. Even the best molecule can be undermined by misuse, counterfeit supply, or casual sharing, all of which erode trust in systems meant to protect people. Seen this way, the discipline of selecting and crediting work on a public platform becomes a reminder that high-quality antibiotics require the same commitment to provenance, verification, and stewardship.